These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26486998)

  • 41. Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.
    Recht A; Comen EA; Fine RE; Fleming GF; Hardenbergh PH; Ho AY; Hudis CA; Hwang ES; Kirshner JJ; Morrow M; Salerno KE; Sledge GW; Solin LJ; Spears PA; Whelan TJ; Somerfield MR; Edge SB
    Pract Radiat Oncol; 2016; 6(6):e219-e234. PubMed ID: 27659727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive value of breast cancer molecular subtypes in Chinese patients with four or more positive nodes after postmastectomy radiotherapy.
    Wu SG; He ZY; Li Q; Li FY; Lin Q; Lin HX; Guan XX
    Breast; 2012 Oct; 21(5):657-61. PubMed ID: 22835918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease.
    Sautter-Bihl ML; Souchon R; Budach W; Sedlmayer F; Feyer P; Harms W; Haase W; Dunst J; Wenz F; Sauer R
    Strahlenther Onkol; 2008 Jul; 184(7):347-53. PubMed ID: 19016032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postmastectomy radiation therapy and survival outcome in older patients with T1-2N1 breast cancer.
    Luo C; Zhong X; Luo T; Zheng H
    Breast; 2021 Oct; 59():308-313. PubMed ID: 34388696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of clinical outcome of breast cancer patients with T1-2 tumor and one to three positive nodes with or without postmastectomy radiation therapy.
    Huang CJ; Hou MF; Chuang HY; Lian SL; Huang MY; Chen FM; Fu OY; Lin SF
    Jpn J Clin Oncol; 2012 Aug; 42(8):711-20. PubMed ID: 22645150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype.
    Wei J; Jiang Y; Shao Z
    Breast; 2020 Jun; 51():40-49. PubMed ID: 32200207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1-3 positive lymph nodes: a retrospective study.
    Chitapanarux I; Tharavichitkul E; Jakrabhandu S; Klunklin P; Onchan W; Srikawin J; Pukanhaphan N; Traisathit P; Vongtama R
    J Radiat Res; 2014 Jan; 55(1):121-8. PubMed ID: 23788495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The significance of risk stratification through nomogram-based assessment in determining postmastectomy radiotherapy for patients diagnosed with pT
    Wei C; Kong J; Han H; Wang X; Gao Z; Wang D; Zhang A; Zhang J; Liu Z
    Radiat Oncol; 2024 Sep; 19(1):120. PubMed ID: 39272162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation.
    Jagsi R; Raad RA; Goldberg S; Sullivan T; Michaelson J; Powell SN; Taghian AG
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1035-9. PubMed ID: 15990006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of postmastectomy radiotherapy in T3N0 invasive carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis.
    McCammon R; Finlayson C; Schwer A; Rabinovitch R
    Cancer; 2008 Aug; 113(4):683-9. PubMed ID: 18543316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trends in use and outcome of postoperative radiotherapy following mastectomy: A population-based study.
    Corradini S; Bauerfeind I; Belka C; Braun M; Combs SE; Eckel R; Harbeck N; Hölzel D; Kiechle M; Niyazi M; Engel J
    Radiother Oncol; 2017 Jan; 122(1):2-10. PubMed ID: 27641786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy.
    Garg AK; Oh JL; Oswald MJ; Huang E; Strom EA; Perkins GH; Woodward WA; Yu TK; Tereffe W; Meric-Bernstam F; Hahn K; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1478-83. PubMed ID: 17855016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Postmastectomy radiotherapy in moderate-and high-risk elderly breast cancer patients].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):863-6. PubMed ID: 20137354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418).
    Kim YJ; Park W; Ha B; Park B; Joo J; Kim TH; Park IH; Lee KS; Lee ES; Shin KH; Kim H; Yu JI; Choi DH; Huh SJ; Wee CW; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Cha J
    Cancer Res Treat; 2017 Oct; 49(4):927-936. PubMed ID: 28052654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postmastectomy radiotherapy in patients with T
    Luo M; Jin Y; Xu C; Chen H; Zhang K; Chen Q; Jin C; Lu J; Wang J; Huang J; Deng H; Jin W; Zheng S; Chen Y; Zhou J
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9979-9990. PubMed ID: 37256383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting patients at low probability of requiring postmastectomy radiation therapy.
    Chagpar AB; Scoggins CR; Martin RC; Cook EF; McCurry T; Mizuguchi N; Paris KJ; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; McMasters KM;
    Ann Surg Oncol; 2007 Feb; 14(2):670-7. PubMed ID: 17096055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimizing locoregional control and survival for women with breast cancer: a review of current developments in postmastectomy radiotherapy.
    Truong PT; Woodward WA; Buchholz TA
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):205-16. PubMed ID: 16445373
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DEGRO practical guidelines for radiotherapy of breast cancer IV: radiotherapy following mastectomy for invasive breast cancer.
    Wenz F; Sperk E; Budach W; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Piroth MD; Sautter-Bihl ML; Sedlmayer F; Souchon R; Fussl C; Sauer R;
    Strahlenther Onkol; 2014 Aug; 190(8):705-14. PubMed ID: 24888511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
    Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is it beneficial for patients with pT1-2N1M0 breast cancer to receive postmastectomy radiotherapy? An analysis based on RecurIndex assay.
    Zhang L; Zhou M; Liu Y; Du F; Tang J; Wang N; Song C; Geng C; Duan H
    Int J Cancer; 2021 Nov; 149(10):1801-1808. PubMed ID: 34224580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.